Victoria Vakiener is Chief Commercial Officer of Epizyme, Inc.. Currently has a direct ownership of 52,685 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Feb 04, 2021, when has been sold 817 shares (Common Stock, par value $0.0001) at a price of $11.21 per share, resulting in proceeds of $9,159. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.7K
0% 3M change
0% 12M change
Total Value Held $0

Victoria Vakiener Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 04 2021
SELL
Open market or private sale
$9,159 $11.21 p/Share
817 Reduced 1.53%
52,685 Common Stock, par valu...
Feb 01 2021
BUY
Grant, award, or other acquisition
-
25,520 Added 32.29%
53,502 Common Stock
Jan 25 2021
SELL
Open market or private sale
$6,835 $11.41 p/Share
599 Reduced 2.1%
27,982 Common Stock, par valu...

Also insider at

CMRX
CHIMERIX INC Healthcare
ARWR
ARROWHEAD PHARMACEUTICALS, INC. Healthcare
VV

Victoria Vakiener

Chief Commercial Officer
Cambridge, MA

Track Institutional and Insider Activities on EPZM

Follow Epizyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPZM shares.

Notify only if

Insider Trading

Get notified when an Epizyme, Inc. insider buys or sells EPZM shares.

Notify only if

News

Receive news related to Epizyme, Inc.

Track Activities on EPZM